Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

Journal of Clinical Oncology

Volumn 19, Issue 4, 2001, Pages 980-991

  Ravdin, P M ^a   Siminoff, L A ^a   Davis, G J ^a   Mercer, M B ^a   Hewlett, J ^a   Gerson, N ^a   Parker, H L ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE;

AGE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CLINICAL TRIAL; COMORBIDITY; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0035865149     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.4.980     Document Type: Article

References (31)

1. Validation studies for models projecting the risk of invasive and total breast cancer incidence
2. Doctor-patient communication about breast cancer adjuvant therapy
3. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy
4. Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer?
5. Polychemotherapy for early breast cancer: An overview of the randomized trials
6. Tamoxifen for early breast cancer: An overview of randomised trials
7. Annual hazard rates of recurrence for breast cancer after primary therapy
8. Time-dependence of hazard ratios for prognostic factors in primary breast cancer
9. Prognostic factors and natural history in lymph node-negative breast cancer patients
10. Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer
11. The sentinel node in breast cancer: A multicenter validation study
12. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up
13. Pathologic correlates of prognosis in lymph node-positive breast carcinomas
14. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma: A study of 97 cases
15. A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma
16. Prognostic importance of occult axillary lymph node micrometastases from breast cancers
17. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction: Comparison between MUC1 mRNA and keratin 19 mRNA amplification
18. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
19. A computer-based program to assist in adjuvant therapy decisions for individual breast cancer patients
20. A computer program to assist in making breast cancer adjuvant therapy decisions
21. How can prognostic and predictive factors in breast cancer be used in a practical way today?
22. Patients assessment of adjuvant treatment in operable breast cancer
23. Late mortality from pT1N0M0 breast carcinoma
24. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: A study of 644 patients with median follow-up of 18 years
25. Natural history of node-negative breast cancer: A study of 826 patients with long-term follow-up
26. Update of recommendations for the use of tumor markers in breast and colorectal cancer
27. Survival advantage of adjuvant chemotherapy in high risk node-negative breast cancer: Ten year analysis